Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation-Reference-Cited by-同舟云学术

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

Published:2018-04-17 Issue:8 Volume:7 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Chan Yi‐Hsin¹²,See Lai‐Chu³⁴⁵,Tu Hui‐Tzu⁴⁵,Yeh Yung‐Hsin¹²,Chang Shang‐Hung¹²,Wu Lung‐Sheng¹²,Lee Hsin‐Fu¹²,Wang Chun‐Li¹²,Kuo Chang‐Fu³²,Kuo Chi‐Tai¹²

Affiliation:

1. Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan

2. College of Medicine, Chang Gung University, Taoyuan, Taiwan

3. Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan

4. Department of Public Health, College of Medicine, Chang Gung University, Taoyuan, Taiwan

5. Biostatistics Core Laboratory, Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

2. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

3. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

4. Apixaban versus Warfarin in Patients with Atrial Fibrillation

5. Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive insight from molecular docking and dynamics with clinical investigation on the impact of direct oral anticoagulants on atheroprotective protein in atrial fibrillation;BMC Pharmacology and Toxicology;2024-08-22

2. Clinical outcomes of patients with atrial fibrillation in relation to multimorbidity status changes over time and the impact of ABC pathway compliance: a nationwide cohort study;Journal of Thrombosis and Thrombolysis;2024-07-09

3. Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case–Control Study in a Real-World Setting;Clinical Therapeutics;2024-07

4. Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study;Frontiers in Cardiovascular Medicine;2024-06-10

5. Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk;Heart Rhythm;2024-06